/
We are a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, and patient monitors. Powered by the Masimo Hospital Automation and Masimo SafetyNet platforms, Masimo connectivity, automation, and telehealth and telemonitoring solutions are improving and automating care delivery …
Margins and capital returns are both well above average: 20.30% operating margin, ROIC at 15.42%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Revenue grew 9.4%, steady but not accelerating.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$1.56B
▲ +9.4% YoY
Net Income (TTM)
$76M
▲ +50.3% YoY
Op. Margin
19.85%
▲ +15.8pp YoY
ROIC
17.79%
▲ +12.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$211M
▲ +13.2% YoY
Op. Cash Flow (TTM)
$232M
▲ +10.9% YoY
Net Debt
$361M
Cash & Equiv.
$125M
5Y CAGR: +5.9%
5Y CAGR: +7.4%
Continue Research